Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2021-2027

免疫性炎症性疾患治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3045
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:90
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、免疫性炎症性疾患治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(生物学的療法、新規療法)、用途別市場規模(病院、薬局、オンライン薬局ストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・免疫性炎症性疾患治療の市場動向
・企業の競争状況、市場シェア
・免疫性炎症性疾患治療の種類別市場規模(生物学的療法、新規療法)
・免疫性炎症性疾患治療の用途別市場規模(病院、薬局、オンライン薬局ストア)
・免疫性炎症性疾患治療の北米市場規模2016-2027(アメリカ、カナダ)
・免疫性炎症性疾患治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・免疫性炎症性疾患治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・免疫性炎症性疾患治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・免疫性炎症性疾患治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(GlaxoSmithKline、Eli Lilly、AstraZeneca、Bristol-Myers、Sanofi、Roche、Enlivex Therapeutics、Immune Pharmaceuticals、Tanabe Pharma)
・結論

Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.

Market Analysis and Insights: Global Immune-Mediated Inflammatory Diseases Treatment Market
The global Immune-Mediated Inflammatory Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immune-Mediated Inflammatory Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immune-Mediated Inflammatory Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immune-Mediated Inflammatory Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immune-Mediated Inflammatory Diseases Treatment market.

Global Immune-Mediated Inflammatory Diseases Treatment Scope and Market Size
Immune-Mediated Inflammatory Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immune-Mediated Inflammatory Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted biologic therapies
Novel therapies

Segment by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted biologic therapies
1.2.3 Novel therapies
1.3 Market by Application
1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2016-2027)
2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions
2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Immune-Mediated Inflammatory Diseases Treatment Industry Dynamic
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Market Trends
2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020
3.5 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
3.7 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
6.2.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
6.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
6.4.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
7.2.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
7.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
7.4.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
9.2.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
9.3.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
9.4.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Details
11.4.2 Bristol-Myers Business Overview
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.4.5 Bristol-Myers Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Details
11.7.2 Enlivex Therapeutics Business Overview
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.7.5 Enlivex Therapeutics Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Details
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.8.5 Immune Pharmaceuticals Recent Development
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Details
11.9.2 Tanabe Pharma Business Overview
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
11.9.5 Tanabe Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted biologic therapies
Table 3. Key Players of Novel therapies
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2016-2021)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027)
Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2016-2021)
Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020)
Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
Table 21. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
Table 64. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Eli Lilly Company Details
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
Table 69. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
Table 74. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Bristol-Myers Company Details
Table 77. Bristol-Myers Business Overview
Table 78. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
Table 79. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 80. Bristol-Myers Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
Table 84. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Immune-Mediated Inflammatory Diseases Treatment Product
Table 89. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Enlivex Therapeutics Company Details
Table 92. Enlivex Therapeutics Business Overview
Table 93. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
Table 94. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 95. Enlivex Therapeutics Recent Development
Table 96. Immune Pharmaceuticals Company Details
Table 97. Immune Pharmaceuticals Business Overview
Table 98. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 99. Immune Pharmaceuticals Recent Development
Table 100. Tanabe Pharma Company Details
Table 101. Tanabe Pharma Business Overview
Table 102. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
Table 103. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
Table 104. Tanabe Pharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Targeted biologic therapies Features
Figure 3. Novel therapies Features
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Pharmacy Store Case Studies
Figure 7. Online Pharmacy Stroe Case Studies
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027)
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2020
Figure 14. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020
Figure 16. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
Figure 20. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
Figure 21. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
Figure 22. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
Figure 26. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
Figure 27. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
Figure 28. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2016-2027)
Figure 38. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 58. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 60. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 63. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 64. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 65. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[免疫性炎症性疾患治療の世界市場規模・現状・予測2021年-2027年] (Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2021-2027 / QY21APR3045)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆